Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (63)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Williams, J.A.
Right arrow Articles by Phillips, D.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, J.A.
Right arrow Articles by Phillips, D.H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 21, No. 9, 1683-1689, September 2000
© 2000 Oxford University Press

Molecular Epidemiology and Cancer Prevention

Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue

J.A. Williams, F.L. Martin, G.H. Muir1, A. Hewer, P.L. Grover and D.H. Phillips2

Institute of Cancer Research, Haddow Laboratories, Cotswold Road, Sutton, Surrey SM2 5NG and
1 Department of Urology, Kings College Hospital, Denmark Hill, London SE5 9RS, UK

Epidemiological evidence suggests a link between meat consumption and prostate cancer. In this study, benign prostatic hyperplasia tissues, obtained by transurethral resection or radical retropubic prostatectomy from UK-resident individuals (n = 18), were examined for CYP1 expression and for their ability, in short-term organ culture, to metabolically activate carcinogens found in cooked meat. Semi-quantitative RT–PCR analysis of CYP1 expression detected CYP1A2 mRNA transcripts in the prostates of four individuals, as well as mRNA transcripts from CYP1A1 and CYP1B1. The compounds tested for metabolic activation were 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP; 500 µM, n = 9) and its metabolite N-hydroxy PhIP (20 µM, n = 8), 2-amino-3-methylimidazo[4,5-f]quinoline (IQ; 500 µM, n = 6) and benzo[a]pyrene (B[a]P; 50 µM, n = 5). After incubation (PFMR medium, 22 h, 37°C), DNA was isolated from tissue fragments and DNA adducts were detected and quantified by 32P-postlabelling analysis. DNA adduct formation was detected in all samples incubated with PhIP (mean, adducts per 108 nucleotides), N-hydroxy-PhIP (2736/108) or B[a]P (1/108). IQ–DNA adducts were detected in 5/6 tissues (mean, 1/108). The CYP1 inhibitor {alpha}-naphthoflavone (10 µM) reduced B[a]P–DNA adduct formation in tissues from two individuals by 96 and 64%, respectively. This pilot study shows that human prostate tissue can metabolically activate `cooked meat' carcinogens, a process that could contribute to prostate cancer development.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
J. Beuten, J. A.L. Gelfond, J. J. Byrne, I. Balic, A. C. Crandall, T. L. Johnson-Pais, I. M. Thompson, D. K. Price, and R. J. Leach
CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic Caucasians
Carcinogenesis, September 1, 2008; 29(9): 1751 - 1757.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
J.-F. Han, X.-Y. He, J. S. Herrington, L. A. White, J.-F. Zhang, and J.-Y. Hong
Metabolism of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by Human CYP1B1 Genetic Variants
Drug Metab. Dispos., April 1, 2008; 36(4): 745 - 752.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. A. Rybicki, C. Neslund-Dudas, C. H. Bock, A. Rundle, A. T. Savera, J. J. Yang, N. L. Nock, and D. Tang
Polycyclic Aromatic Hydrocarbon-DNA Adducts in Prostate and Biochemical Recurrence after Prostatectomy
Clin. Cancer Res., February 1, 2008; 14(3): 750 - 757.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. Koutros, A. J. Cross, D. P. Sandler, J. A. Hoppin, X. Ma, T. Zheng, M. C.R. Alavanja, and R. Sinha
Meat and Meat Mutagens and Risk of Prostate Cancer in the Agricultural Health Study
Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 80 - 87.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
D. Tang, J. J. Liu, A. Rundle, C. Neslund-Dudas, A. T. Savera, C. H. Bock, N. L. Nock, J. J. Yang, and B. A. Rybicki
Grilled Meat Consumption and PhIP-DNA Adducts in Prostate Carcinogenesis
Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 803 - 808.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
T. M. Sissung, D. K. Price, A. Sparreboom, and W. D. Figg
Pharmacogenetics and Regulation of Human Cytochrome P450 1B1: Implications in Hormone-Mediated Tumor Metabolism and a Novel Target for Therapeutic Intervention
Mol. Cancer Res., March 1, 2006; 4(3): 135 - 150.
[Abstract] [Full Text] [PDF]

Home page
 J AndrolHome page
R. Obligacion, M. Murray, and I. Ramzan
Drug-Metabolizing Enzymes and Transporters: Expression in the Human Prostate and Roles in Prostate Drug Disposition
J Androl, March 1, 2006; 27(2): 138 - 150.
[Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
Y. Tanaka, M. Sasaki, H. Shiina, T. Tokizane, M. Deguchi, H. Hirata, Y. Hinoda, N. Okayama, Y. Suehiro, S. Urakami, et al.
Catechol-O-methyltransferase Gene Polymorphisms in Benign Prostatic Hyperplasia and Sporadic Prostate Cancer.
Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 238 - 244.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. J. Cross, U. Peters, V. A. Kirsh, G. L. Andriole, D. Reding, R. B. Hayes, and R. Sinha
A Prospective Study of Meat and Meat Mutagens and Prostate Cancer Risk
Cancer Res., December 15, 2005; 65(24): 11779 - 11784.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Tokizane, H. Shiina, M. Igawa, H. Enokida, S. Urakami, T. Kawakami, T. Ogishima, S. T. Okino, L.-C. Li, Y. Tanaka, et al.
Cytochrome P450 1B1 Is Overexpressed and Regulated by Hypomethylation in Prostate Cancer
Clin. Cancer Res., August 15, 2005; 11(16): 5793 - 5801.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. A. Rybicki, A. Rundle, A. T. Savera, S. S. Sankey, and D. Tang
Polycyclic Aromatic Hydrocarbon-DNA Adducts in Prostate Cancer
Cancer Res., December 15, 2004; 64(24): 8854 - 8859.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
R. Rodriguez-Melendez, J. B. Griffin, and J. Zempleni
Biotin Supplementation Increases Expression of the Cytochrome P450 1B1 Gene in Jurkat Cells, Increasing the Occurrence of Single-Stranded DNA Breaks
J. Nutr., September 1, 2004; 134(9): 2222 - 2228.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. Nowell, D. L. Ratnasinghe, C. B. Ambrosone, S. Williams, T. Teague-Ross, L. Trimble, G. Runnels, A. Carrol, B. Green, A. Stone, et al.
Association of SULT1A1 Phenotype and Genotype with Prostate Cancer Risk in African-Americans and Caucasians
Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 270 - 276.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
P. L. Grover and F. L. Martin
The initiation of breast and prostate cancer
Carcinogenesis, July 1, 2002; 23(7): 1095 - 1102.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Murata and S. Kawanishi
Oxidation of 5'-site guanine at GG and GGG sequences induced by a metabolite of carcinogenic heterocyclic amine PhIP in the presence of Cu(II) and NADH
Carcinogenesis, May 1, 2002; 23(5): 855 - 860.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J.A. Williams
Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: why molecular epidemiologists should think about enzyme expression
Carcinogenesis, February 1, 2001; 22(2): 209 - 214.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.